3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
21
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
7
Leukemia, Myeloid, Acute
4
Sarcoma
3
Endometrial Neoplasms
3
Primary Myelofibrosis
2
Neurofibrosarcoma
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell
2
Glioblastoma
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Vascular Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Triple Negative Breast Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Interventions
Cyclophosphamide
43
venetoclax
30
Cytarabine
25
fludarabine
22
fludarabine phosphate
17
Azacitidine
16
Mycophenolic Acid
13
Whole-Body Irradiation
12
Dexamethasone
12
Rituximab
11
Busulfan
11
ruxolitinib
10
Vincristine
10
Methotrexate
10
Etoposide
10
Tacrolimus
9
Mercaptopurine
9
Daunorubicin
9
Prednisone
8
Filgrastim
8
Dasatinib
8
ibrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Granulocyte Colony-Stimulating Factor
7
Doxorubicin
7
Decitabine
7
pegaspargase
6
blinatumomab
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
selinexor
×
1 year
×
Clear all
No trials found.